A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment
about
Recommended patient-reported core set of symptoms to measure in adult cancer treatment trialsPrevalence of symptoms in patients with multiple myeloma: a systematic review and meta-analysis.The validity and utility of the MD Anderson Symptom Inventory in patients with prostate cancer: evidence from the Symptom Outcomes and Practice Patterns (SOAPP) data from the Eastern Cooperative Oncology GroupComputerized patient-reported symptom assessment in radiotherapy: a pilot randomized, controlled trial.Measuring symptoms as a critical component of drug development and evaluation in hematological diseasesCytokine gene variations associated with trait and state anxiety in oncology patients and their family caregivers.The Potential Role of Symptom Questionnaires in Palliative and Supportive Cancer Care DeliveryDevelopment of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse EventThe Complementary Nature of Patient-Reported Outcomes and Adverse Event Reporting in Cooperative Group Oncology Clinical Trials: A Pooled Analysis (NCCTG N0591).The symptom burden of primary brain tumors: evidence for a core set of tumor- and treatment-related symptomsSymptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial.The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study.Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial.A role for orexin in cytotoxic chemotherapy-induced fatigue.Pharmacological management of depression in patients with cancer: practical considerations.Acupuncture in the treatment of cancer-related psychological symptoms.Challenges in managing hepatitis C virus infection in cancer patients.Patient reported endpoints for measuring clinical benefit in (high grade glioma) primary brain tumor patients.Congruence Between Latent Class and K-modes Analyses in the Identification of Oncology Patients with Distinct Symptom Experiences.Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry.Electronic-Based Patient-Reported Outcomes: Willingness, Needs, and Barriers in Adjuvant and Metastatic Breast Cancer Patients.Conducting Biobehavioral Research in Patients With Advanced Cancer: Recruitment Challenges and Solutions.Self-management education interventions for patients with cancer: a systematic review.Symptom incidence, distress, cancer-related distress, and adherence to chemotherapy among African American women with breast cancer.Patient-reported outcomes in cancer survivorship.Variation in symptom distress in underserved Chinese American cancer patients.Using patient-reported outcome measures as quality indicators in routine cancer careDetecting lung cancer relapse using self-evaluation forms weekly filled at home: the sentinel follow-up.Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment.Physician perspective on incorporation of oncology patient quality-of-life, fatigue, and pain assessment into clinical practice.Physical, Psychological, Social, and Existential Symptoms in Older Homeless-Experienced Adults: An Observational Study of the Hope Home Cohort.Patient-reported symptoms during radiotherapy : Clinically relevant symptom burden in patients treated with palliative and curative intent.The Role of Inflammation in the Pain, Fatigue, Sleep Disturbance Symptom Cluster in Advanced Cancer.Effects of web-based interventions on cancer patients' symptoms: review of randomized trials.Oxaliplatin induces muscle loss and muscle-specific molecular changes in MICE.Administration of chemotherapy with palliative intent in the last 30 days of life: the balance between palliation and chemotherapy.Prevalence of Symptoms and Quality of Life Among Jordanian Cancer Patients.Symptom Prevalence, Symptom Severity, and Health-Related Quality of Life Among Young, Middle, and Older Adults With Pulmonary Arterial Hypertension.What are the best terms in Portuguese to explain the concepts of "fatigue" and "depression" in cancer patients?
P2860
Q28655361-4B756DB4-0F60-4155-810B-0897C2138035Q30248483-F04587A3-40B4-44FD-BAC0-5F971FC0E085Q30677640-AEC1C5F6-221C-4501-9455-5F4FE482531AQ30718673-176DD49B-C3EF-4A0C-9BC9-924A7934661BQ33705743-5E43916B-228A-44EE-AE4E-CEA12EFC204FQ33809141-4BAABE3C-290D-4779-A5D0-3B0639E91497Q33900714-492D8256-32AC-43AA-833C-FF8515CDA43DQ34354355-63B3E3D5-35D4-48E4-9876-CB25915CBC48Q35927927-B4E504DE-21B3-4DC9-B4DF-0865383D5477Q36311501-6F51B5BF-5A0E-468D-8CE0-DFDBDFA7D59FQ36493829-0C7269F6-47EE-47AA-AAA7-CDDA6E7B1107Q36914459-5307E9C6-E322-4CAE-AEEE-5CCB0410BDEEQ37385996-861C480C-603E-4816-A86B-29859DCEA46FQ37582287-6F6B9ACF-EB2F-435A-9942-056DEB6DF80FQ37633462-5FFD1152-2C2E-411D-8687-65C362536A05Q38120495-884E84A8-0AF1-428D-A5D8-C518794C48ACQ38185632-8647A861-70F2-49EC-96FC-8055D77B3E42Q38198615-CB0E9ADF-0E2E-4B29-8DB1-8237F859DD2BQ38244843-A4C43AD3-C960-4592-9795-696FFE5445B7Q38599341-A5441BAA-E6D7-4D77-BFA7-3FF3ACE30AA8Q38606464-A2B9630C-AF5C-4F6A-B20E-49261CE2FF99Q38636290-8DCD7CD6-044D-42A3-91C0-01CE3B61EB53Q38785360-D0B2E141-FB6C-4219-9A8B-004DC4E65A3BQ39069539-1A24F623-93C8-4FCA-A828-184536C21AC6Q40335346-871A3422-8BDA-41E5-A8D3-0B17DFF2069DQ40382166-3A60C33B-6D09-46F0-862B-F57E7F725FC4Q40851917-CC5609EB-2D97-4FCB-B5F1-C511B1156451Q42331894-69AB0C3B-CADC-46AF-908E-0C6376E4A1CFQ44271210-0D54AA85-12DF-48B4-9CFC-93819A75673DQ45060789-A05E8DBF-FE87-4179-A3DF-FC4F31752FC1Q47110733-7FD0BDC4-1142-4891-AE8D-4F868E9969C2Q47282354-7CFEF18C-A5E0-466B-8DE6-7A174BDFED57Q47559496-CCA03B86-B8C2-429C-A604-5DCF727562EEQ47642060-D300D9F8-7C93-4368-AFAD-4DF152A5EEC9Q47766652-359FB12A-D339-4F4C-B2BE-130819E4E1BBQ47841514-3C8892DB-70C1-4374-8C1E-DAE8D0BAEA96Q47867315-F4B41783-1B2E-4829-8C28-20C05835BCC0Q48054607-12AA794C-CAD3-42CE-92FD-49766E1C7125Q48063470-A41E5519-AD64-4B47-9324-5C01B5147E9DQ48240487-6211FE05-CE1E-4523-BE5C-4849B7F9DDB6
P2860
A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A literature synthesis of symp ...... eiving active cancer treatment
@ast
A literature synthesis of symp ...... eiving active cancer treatment
@en
A literature synthesis of symp ...... eiving active cancer treatment
@nl
type
label
A literature synthesis of symp ...... eiving active cancer treatment
@ast
A literature synthesis of symp ...... eiving active cancer treatment
@en
A literature synthesis of symp ...... eiving active cancer treatment
@nl
prefLabel
A literature synthesis of symp ...... eiving active cancer treatment
@ast
A literature synthesis of symp ...... eiving active cancer treatment
@en
A literature synthesis of symp ...... eiving active cancer treatment
@nl
P2093
P2860
P1476
A literature synthesis of symp ...... eiving active cancer treatment
@en
P2093
Amylou C Dueck
Bryce B Reeve
Carolyn Miller Reilly
Deborah Watkins Bruner
Lori M Minasian
Sandra A Mitchell
P2860
P2888
P304
P356
10.1007/S00520-012-1688-0
P577
2013-01-12T00:00:00Z